Participants in this roundtable discussion focused on new financing models that can help spur medical discoveries.
Current models for funding early-stage health-care innovations leave many promising firms without cash or out of business, while others never get through to a first round of investment. Communication between the innovators and investors is inefficient. The innovations that do get funded usually meet specific sweet-spot investment criteria for returns, leaving many other opportunities unfunded. How can we change this so that young innovators, especially in the area of biotechnology, get the capital they need to discover new, potentially life-saving drugs? One new model has successfully funded innovations in cardiovascular disease, stem-cell harvesting, non-toxic cancer treatments and drug-delivery innovations, generating good returns on private-investment capital and public-equity share price appreciation. Other approaches pool patents to spread risk across multiple opportunities. This session will explore various ways to use alternative financing vehicles to fund medical innovation.
Global Conference 2013
Former Prime Minister Tony Blair, philanthropist Bill Gates and Strive Masiyiwa of Econet Wireless discuss advancing prosperity in Africa.
